These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36509688)

  • 41. Cervical cancer screening uptake among HIV-positive women in Ontario, Canada: A population-based retrospective cohort study.
    Burchell AN; Kendall CE; Cheng SY; Lofters A; Cotterchio M; Bayoumi AM; Glazier RH; Antoniou T; Raboud J; Yudin MH; Loutfy M
    Prev Med; 2018 Feb; 107():14-20. PubMed ID: 29197533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening.
    Poljak M; Cuschieri K; Waheed DE; Baay M; Vorsters A
    Acta Dermatovenerol Alp Pannonica Adriat; 2021 Mar; 30(1):21-26. PubMed ID: 33765753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
    Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
    BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
    Fokom Domgue J; Cunningham SA; Yu RK; Shete S
    Ann Epidemiol; 2019 Aug; 36():40-47. PubMed ID: 31320153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program.
    Smith M; Lew JB; Simms K; Canfell K
    Med J Aust; 2016 Mar; 204(5):1941e-7. PubMed ID: 26985849
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
    PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Cervical cancer screening in Switzerland - current practice and future challenges].
    Untiet S; Schmidt N; Low N; Petignat P
    Ther Umsch; 2013 Apr; 70(4):223-30. PubMed ID: 23535549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Forslund O; Hansson BG; Hagmar B; Johansson B; Rylander E; Dillner J
    J Natl Cancer Inst; 2009 Jan; 101(2):88-99. PubMed ID: 19141778
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cervical cancer prevention in Australia: Planning for the future.
    Saville AM
    Cancer Cytopathol; 2016 Apr; 124(4):235-40. PubMed ID: 26619381
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
    Cuzick J; Du R; Adcock R; Kinney W; Joste N; McDonald RM; English K; Torres SM; Saslow D; Wheeler CM;
    Gynecol Oncol; 2021 Sep; 162(3):555-559. PubMed ID: 34253387
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uptake and correlates of cervical cancer screening among women attending a community-based multi-disease health campaign in Kenya.
    Choi Y; Ibrahim S; Park LP; Cohen CR; Bukusi EA; Huchko MJ
    BMC Womens Health; 2022 Apr; 22(1):122. PubMed ID: 35436908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levels of anxiety and distress following receipt of positive screening tests in Australia's HPV-based cervical screening programme: a cross-sectional survey.
    Dodd RH; Mac O; Brotherton JML; Cvejic E; McCaffery KJ
    Sex Transm Infect; 2020 May; 96(3):166-172. PubMed ID: 32001660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society.
    Fontham ETH; Wolf AMD; Church TR; Etzioni R; Flowers CR; Herzig A; Guerra CE; Oeffinger KC; Shih YT; Walter LC; Kim JJ; Andrews KS; DeSantis CE; Fedewa SA; Manassaram-Baptiste D; Saslow D; Wender RC; Smith RA
    CA Cancer J Clin; 2020 Sep; 70(5):321-346. PubMed ID: 32729638
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for cervical cancer: new alternatives and research.
    Lörincz AT
    Salud Publica Mex; 2003; 45 Suppl 3():S376-87. PubMed ID: 14746031
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perspectives from health-care providers and women about completing human papillomavirus (HPV) self-testing at home.
    Katz ML; Zimmermann BJ; Moore D; Paskett ED; Reiter PL
    Women Health; 2017; 57(10):1161-1177. PubMed ID: 27700693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of cervical cancer screening among Medicaid beneficiaries.
    Dillon J; Chen L; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL; Wright JD
    BJOG; 2022 Jun; 129(7):1104-1111. PubMed ID: 34882962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.